| March 23, 2020 |
H.R.6373 |
To increase the amount available under the Defense Production Act of 1950 to respond to the coronavirus epidemic, and for other purposes. |
1 |
All Democrats |
Referred to the House Committee on Financial Services. |
| Sept. 27, 2019 |
H.R.4548 |
To authorize the Director of the Centers for Disease Control and Prevention to award grants to eligible counties for the use of mobile clinics and distance learning and telemedicine to diagnose and treat children with asthma in rural areas and medically underserved communities, and for other purposes. |
4 |
All Democrats |
Referred to the Subcommittee on Health. |
| Sept. 13, 2018 |
H.R.6801 |
To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes. |
2 |
Bipartisan |
Referred to the House Committee on Energy and Commerce. |
| Oct. 9, 2015 |
H.R.3731 |
To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes. |
1 |
All Republicans |
Referred to the Subcommittee on Health. |
| Feb. 5, 2015 |
H.RES.95 |
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research. |
2 |
All Democrats |
Referred to the Subcommittee on Health. |
| July 31, 2014 |
H.RES.709 |
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research. |
6 |
Bipartisan |
Referred to the Subcommittee on Health. |
Searching...